Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Applied Therapeutics Inc (NASDAQ: APLT) closed at $5.86 in the last session, down -7.57% from day before closing price of $6.34. In other words, the price has decreased by -$7.57 from its previous closing price. On the day, 1.24 million shares were traded. APLT stock price reached its highest trading level at $6.74 during the session, while it also had its lowest trading level at $5.8.
Ratios:
We take a closer look at APLT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.30 and its Current Ratio is at 2.30. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On March 26, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $12.
On February 22, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $12.Leerink Partners initiated its Outperform rating on February 22, 2024, with a $12 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 22 ’24 when Funtleyder Leslie D. sold 13,530 shares for $5.83 per share. The transaction valued at 78,880 led to the insider holds 277,911 shares of the business.
Perfetti Riccardo sold 22,681 shares of APLT for $132,230 on Aug 22 ’24. The Chief Medical Officer now owns 986,853 shares after completing the transaction at $5.83 per share. On Aug 13 ’24, another insider, Shendelman Shoshana, who serves as the President and CEO of the company, sold 357,423 shares for $6.18 each. As a result, the insider received 2,208,874 and left with 4,810,430 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLT now has a Market Capitalization of 728122624 and an Enterprise Value of 551017152. For the stock, the TTM Price-to-Sale (P/S) ratio is 63.14 while its Price-to-Book (P/B) ratio in mrq is 9.30. Its current Enterprise Value per Revenue stands at -1654.706 whereas that against EBITDA is -7.061.
Stock Price History:
Over the past 52 weeks, APLT has reached a high of $9.39, while it has fallen to a 52-week low of $1.22. The 50-Day Moving Average of the stock is 7.22%, while the 200-Day Moving Average is calculated to be 30.26%.
Shares Statistics:
According to the various share statistics, APLT traded on average about 1.23M shares per day over the past 3-months and 998520 shares per day over the past 10 days. A total of 114.85M shares are outstanding, with a floating share count of 85.85M. Insiders hold about 25.24% of the company’s shares, while institutions hold 79.94% stake in the company. Shares short for APLT as of 1723680000 were 9558691 with a Short Ratio of 7.78, compared to 1721001600 on 9099493. Therefore, it implies a Short% of Shares Outstanding of 9558691 and a Short% of Float of 9.3.
